| Dr Louis A Deporter, MD | |
|
7905 Calumet Ave, Munster, IN 46321-1215 | |
| (219) 836-7214 | |
| (219) 836-5030 |
| Full Name | Dr Louis A Deporter |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 7905 Calumet Ave, Munster, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235178492 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 01020642A (Indiana) | Primary |
| Entity Name | Franciscan Physician Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225327984 PECOS PAC ID: 3072790682 Enrollment ID: O20110608000486 |
News Archive
Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company primarily focused on the pediatric market, today announced the acquisition of 100% of the outstanding membership interest in Macoven Pharmaceuticals, L.L.C. for approximately $2.2 million (which includes inventory of approximately $1.2 million), its entry into a $10 million credit facility with Regions Bank and the repurchase of 2,000,000 shares of its common stock from one of its employees in a privately negotiated transaction.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, if Pfizer/Medivation's Dimebon shows efficacy in two ongoing clinical trials in moderate to severe Alzheimer's disease that is equivalent to the impressive clinical trial data it has already shown to date in mild to moderate patients, these positive data would promote the use of Dimebon throughout the course of the disease.
A team of scientists from the United States has recently examined the trajectory of early immune biomarkers in response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. They have identified specific plasma proteins that can accurately predict the clinical and virological outcomes in SARS-CoV-2 infected patients. The study is currently available on the medRxiv* preprint server.
Young competitive athletes are perceived by the general population to be the healthiest members of society. The possibility that highly trained athletes may have a potentially serious cardiac condition that can predispose to life-threatening tachyarrhythmias or sudden cardiac death seems paradoxical.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Louis A Deporter, MD 7905 Calumet Ave, Munster, IN 46321-1215 Ph: (219) 836-7214 | Dr Louis A Deporter, MD 7905 Calumet Ave, Munster, IN 46321-1215 Ph: (219) 836-7214 |
News Archive
Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company primarily focused on the pediatric market, today announced the acquisition of 100% of the outstanding membership interest in Macoven Pharmaceuticals, L.L.C. for approximately $2.2 million (which includes inventory of approximately $1.2 million), its entry into a $10 million credit facility with Regions Bank and the repurchase of 2,000,000 shares of its common stock from one of its employees in a privately negotiated transaction.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, if Pfizer/Medivation's Dimebon shows efficacy in two ongoing clinical trials in moderate to severe Alzheimer's disease that is equivalent to the impressive clinical trial data it has already shown to date in mild to moderate patients, these positive data would promote the use of Dimebon throughout the course of the disease.
A team of scientists from the United States has recently examined the trajectory of early immune biomarkers in response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. They have identified specific plasma proteins that can accurately predict the clinical and virological outcomes in SARS-CoV-2 infected patients. The study is currently available on the medRxiv* preprint server.
Young competitive athletes are perceived by the general population to be the healthiest members of society. The possibility that highly trained athletes may have a potentially serious cardiac condition that can predispose to life-threatening tachyarrhythmias or sudden cardiac death seems paradoxical.
› Verified 2 days ago
Fardad Massoumi Bavil, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7905 Calumet Ave, Munster, IN 46321 Phone: 219-836-3049 Fax: 219-836-7295 | |
Raymond Loza, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7905 Calumet Ave, Munster, IN 46321 Phone: 219-836-5800 Fax: 219-836-7295 | |
Jonathan Jones, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 929 Ridge Rd Ste 7, Munster, IN 46321 Phone: 219-836-9515 Fax: 219-836-8547 | |
Dr. Olayemi O Champion-odusola, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7905 Calumet Ave, Munster, IN 46321 Phone: 219-836-5800 Fax: 219-836-5030 | |
Farah Najamuddin, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7905 Calumet Ave, Munster, IN 46321 Phone: 219-836-5800 Fax: 219-836-7295 | |
Sameea A Chughtai, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7905 Calumet Ave, Franciscan Hammond Clinic Llc, Munster, IN 46321 Phone: 219-836-5800 Fax: 219-836-8073 | |
Dr. Donald E. Stork, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7905 Calumet Ave, Hammond Clinic Llc, Munster, IN 46321 Phone: 219-836-7214 Fax: 219-924-8794 |